HB4953 - 104th General Assembly (2025-2026)

DRUG DISTRIBUTION RESTRICTIONS
Last Action
2/06/2026 - House: Referred to Rules Committee
House Sponsors
Rep. Martha Deuter
Statutes Amended In Order of Appearance
225 ILCS 120/56  
Synopsis As Introduced
Amends the Wholesale Drug Distribution Licensing Act. In provisions concerning restrictions on transactions, provides that prescription drugs furnished by a manufacturer or wholesale distributor licensed under the Act may be delivered only to the business address of a licensee registered with the Department of Financial and Professional Regulation, to the premises listed on a license, or, if the Department has received notice that the licensee has authorized a health care entity to receive the prescription drugs, to the address of a health care entity (instead of only to the premises listed on the license). Provides that "health care entity" means an entity where medical, dental, or veterinary services are provided by a licensed practitioner and where the licensed practitioner is responsible for the receipt, storage, and use of drugs.
Actions
DateChamberAction
2/04/2026HouseFiled with the Clerk by Rep. Martha Deuter
2/06/2026HouseFirst Reading
2/06/2026HouseReferred to Rules Committee